Mode
Text Size
Log in / Sign up
N/A N=143 Randomized Single-blind Health Services Research

The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation

Cancer · Bone Marrow Neoplasms · Anxiety · Depression · Quality of Life

Enrolled (actual)
143
Serious AEs
0.0%
Results posted
Oct 2024
Primary outcome: Primary: Hospital Anxiety & Depression Scale (HADS) Score - Depression Sub-score — 4.55; 4.03 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
PRISM (Promoting Resilience in Stress Management) (Behavioral)
Age
Pediatric, Adult · 12+ yrs
Sex
All
Sponsor
Seattle Children's Hospital
Primary completion
Mar 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Hospital Anxiety & Depression Scale (HADS) Score - Depression Sub-score
4.55; 4.03
SECONDARY
PedsQL Generic Core and Cancer-Related Quality of Life Score
73.48; 77.14
SECONDARY
Connor-Davidson Resilience Scale
27.65; 29.64
SECONDARY
Hope Scale Scores
47.21; 49.37
SECONDARY
Hospital Anxiety & Depression Scale Score - Anxiety Sub-score
5.86; 5.13
SECONDARY
Generalized Anxiety Disorder Screener (GAD7)
5.3
SECONDARY
Patient Health Questionnaire-8
4.5
SECONDARY
Medical Outcomes Study Rand 36-item Health Survey
72.0

Summary

Multisite Randomized Controlled Trial (RCT) testing the efficacy of the Promoting Resilience in Stress Management (PRISM) intervention among Adolescents and Young Adults receiving hematopoietic cell transplantation for hematology malignancy.

Eligibility Criteria

Inclusion Criteria for adolescent/young adult (AYA) patient:

  • Patient aged 12-24 years
  • Receiving hematopoietic cell transplantation (HCT) for malignancy or cancer predisposition syndrome
  • Within 4 weeks of HCT "day zero"
  • Able to speak English
  • Able to read English or Spanish
  • Cognitively able to participate in interviews

Exclusion Criteria for AYA patient:

  • Patient refusal
  • Cognitively or physically unable to participate in interviews
  • Unable to speak English
  • Unable to read English or Spanish

For enrolled caregivers of AYA patient (no age limit):

Inclusion criteria

  • AYA Child of caregiver agreed to participate
  • One caregiver per patient-caregiver dyad
  • Parent/guardian cognitively and physically able to participate
  • Parent/guardian is able to speak/read English or Spanish
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03640325). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search